Why Physitrack stock moves
Physitrack slipped slightly, in line with the market.
Written after the close on ·
Why today
16,415 news analyzed todayPhysitrack slipped slightly, in line with the market.
Over the last five trading days Physitrack fell sharply while OMX Stockholm 30 was roughly flat, a big move for the stock.
In the last session it fell slightly, with the market falling clearly, so the move was ordinary for Physitrack.
No company news from that session explains it.
Earlier news, the launch of its AI electronic medical record open to all markets on November 2, was known before the session opened.
Today's move of −1.40% was 1.0 times a normal day's 1.4%. OMX Stockholm 30 moved −1.01% on the same day.
Physitrack −1.40%OMX Stockholm 30 −1.01%In step with the market
What analysts expect, and how often they have been right
Analysts’ estimates for Physitrack.
Price targets
Latest price 10.55 SEK
For the current fiscal year, expected earnings per share changed from 0.10 EUR three months ago to 0.03 EUR now. 2026 estimate: 0.03 EUR. 2027 estimate: 0.05 EUR. One analyst made these estimates.
What the key figures say about Physitrack
The figures connect what Physitrack earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.54 EUR–0.17 EUR. Peers: Aiforia Technologies -0.42 EUR, Carasent 0.59 SEK, NordHealth -2.32 NOK. 2026 estimate: 0.03 EUR (0.03 EUR–0.03 EUR). 2027 estimate: 0.05 EUR (0.05 EUR–0.05 EUR).
What the company sold during the year.
2022–2025: 12.5 m EUR–14.7 m EUR. Peers: Aiforia Technologies 2.9 m EUR, Carasent 390 m SEK, NordHealth 53.1 m EUR. 2026 estimate: 13.9 m EUR (13.9 m EUR–13.9 m EUR). 2027 estimate: 15.8 m EUR (15.8 m EUR–15.8 m EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: −6.4%–3.8%. Peers: Aiforia Technologies −316.4%, Carasent 4.1%, NordHealth −28.4%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −87.2%–11.2%. Peers: Aiforia Technologies −77.5%, Carasent 4.8%, NordHealth −25.8%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 0.10–0.99. Peers: Carasent -0.71.
More key figures
Cash left after investments, divided by the number of shares.
2022–2025: -0.19 EUR–0.08 EUR. Peers: Aiforia Technologies -0.38 EUR, Carasent 0.87 SEK, NordHealth -0.09 EUR.
The percentage of assets financed by shareholders’ equity.
2022–2025: 52.0%–65.8%.
What followed similar falls?
Including reinvested dividends, Physitrack fell 9.1% over the latest five trading days. Since June 18, 2021, falls at least this large were followed by a higher value 21 trading days later in 16 out of 32 non-overlapping periods. The median was +0.1%, against −2.4% for an ordinary 21-day period, which ended higher 43 times in 100.
Such a fall has not said much about the next month.
+0.1% · 16/32
Earnings report
On its last 16 report days Physitrack usually moved about 7.5%. On a normal day it moves 1.4%.
+2.48% +10.28% −4.22% +1.93%
10,000 SEK in Physitrack bought on June 18, 2021 is worth 2,270 SEK today, with dividends reinvested.
The same amount in OMX Stockholm 30 with dividends would have become 16,800 SEK.
What would 10,000 SEK in Physitrack be worth today? →
What would 10,000 SEK in Physitrack be worth today?
2,270 SEK
with dividends reinvested, bought on June 18, 2021. The same amount in OMX Stockholm 30 with dividends would have become 16,800 SEK.
At worst it was worth 1,580 SEK (July 13, 2026).
The five biggest days of the journey
· −22.0% · the whole market fell 2.4% the same day · report day
· −19.9% · the whole market fell 0.4% the same day · report day
· +18.2% · the whole market rose 1.0% the same day
· −17.1% · the whole market rose 0.7% the same day · report day
· −16.3% · the whole market rose 2.2% the same day · report day
Earlier days
−9.05% market −0.11% Physitrack fell sharply over the week, while the OMX Stockholm 30 index stayed roughly flat. Read →
Physitrack fell sharply over the week, while the OMX Stockholm 30 index stayed roughly flat.
The drop was big for the company, rare compared with its usual weekly moves over the past year.
Company news was mostly positive: on November 2 it opened its AI-based electronic medical record system to clinics in every market, with no waitlist.
That announcement likely did not lift the shares, so the cause of the fall is unclear from the news.
+1.42% market −0.32% Physitrack, a Healthcare company, rose without a company-news explanation. Read →
Physitrack, a Healthcare company, rose without a company-news explanation.
The move was ordinary for the stock and went against a slightly weaker OMX Stockholm 30.
Over the last five trading days, Physitrack fell very sharply while the market rose slightly, a very big move for this stock.
The news from that day on the CEO's launch and AI plans came out after trading had closed, so it cannot explain the session.
−3.65% market +0.83% Physitrack fell over the last 5 trading days. Read →
Physitrack fell over the last 5 trading days.
The last session saw a sharp fall while OMX Stockholm 30 rose clearly, so no company news explains that session's drop.
Over the five days it was a very big move, rarer than any seen in the past year.
Physitrack launched its AI electronic medical record to all markets on Monday, and it plans to charge for it from January 2027.
Trading volume was well below its usual level, so the fall came on thin trading.
−3.10% market −0.08% Physitrack fell after launching its AI medical record system. Read →
Physitrack fell after launching its AI medical record system.
Physitrack fell sharply in the last session, while OMX Stockholm 30 was roughly flat.
The launch of its agentic AI EMR, opened to clinics worldwide with no waitlist, is the reason.
Over the last five trading days the stock fell very sharply, while the market rose slightly.
The move was very big for Physitrack, about three times a normal five-day stretch.
−2.59% market +0.48% Physitrack fell without company news. Read →
Physitrack fell without company news.
Over the last five trading days, Physitrack fell sharply while OMX Stockholm 30 rose clearly, a big move for the stock.
In the last session, Physitrack fell clearly while OMX Stockholm 30 rose slightly, so it moved against the market.
Trading volume was well above its usual level for the stock.
The stock sits between its highest and lowest closes of the past year.
−7.94% market −0.29% Physitrack fell very sharply. Read →
Physitrack fell very sharply.
The move was very big for Physitrack, about five times a normal day, and similar drops happened roughly ten times in the past year.
No company news from that session explains it.
Over the last five trading days Physitrack fell clearly while the market rose, so it moved against the market.
Earlier company news, including the CEO buying shares and the quarterly report, is background and does not explain the session's drop.
−6.45% market +3.01% Physitrack fell clearly over the week while the broader market rose clearly. Read →
Physitrack fell clearly over the week while the broader market rose clearly.
The fall was big, roughly twice a normal five-day stretch for the company.
The steepest drop came in the last session, when it fell very sharply as the market slipped slightly.
Its third-quarter report, published on 20 October, showed record revenue up 14 per cent, but no company news clearly explains the decline.
+2.38% market +0.33% Physitrack rose clearly, without company news. Read →
Physitrack rose clearly, without company news.
No company news from that session explains the move.
Over the last five trading days it rose clearly while the market rose slightly.
The latest Q3 report, published before the session, showed revenue up 14 per cent but adjusted EBITDA down 8 per cent.
Trading volume was well below its usual level.
Learn more · Why do stocks go up and down?